December 6, 2007 – Patients treated with a rotablator drill less risk of perforation than those treated with the excimer ...
December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V ...
December 6, 2007 - The first commercial implant of the Mitroflow Aortic Pericardial Heart Valve in the U.S. was ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 5, 2007 - The United Kingdom's Department of Health said today it will begin a new stroke strategy in which ...
Starion Instruments' TLS3 Tissue Ligating Shears feature Starion’s proprietary thermal welding technology, focusing ...
December 5, 2007 - Bristol-Myers Squibb will divest its medical imaging division as part of an initiative to maximize ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 4, 2007 – American College of Cardiology CEO Jack Lewin has urged ACC members this week to let "their members ...
December 4, 2007 - InSite One’s InDex Archive surpassed 1.5 billion individual images and over 20 million studies stored ...
December 4, 2007 - Two special electrocardiograms (EKG) can help predict heart-related death or cardiac arrest after a ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 4, 2007- Berlin Heart announced the first patient enrollment in the prospective IDE study for its EXCOR Paediatric VAD, a mechanical cardiac support system for critically ill pediatric patients suffering from severe heart failure.
December 4, 2007 - SRSsoft today announced the Cardiovascular Institute of the South (CIS) has selected SRSsoft Clinical ...
December 4, 2007 - In general, drug-eluting stents (DES) achieve better results than bare-metal stents do, U.S ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 4, 2007 – The Impella 2.5, a catheter-based heart pump device, supports high-risk patient’s weakened heart in ...
December 4, 2007 - Patients treated with Abbott Laboratories Inc.’s experimental drug-coated heart stent had low rates ...
December 4, 2007 - ELA Medical Inc. intiated U.S. enrollment in the OPTION study (Optimal Anti-tachycardia Therapy in ICD Patients without Pacing Indications), which will evaluate therapies and advanced algorithms in optimizing treatment and managing ICD patients.